Lucas C Quarantini
Overview
Explore the profile of Lucas C Quarantini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
862
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leal G, Lima-Araujo I, Roiter D, Caliman-Fontes A, Mello R, Kapczinski F, et al.
Eur Arch Psychiatry Clin Neurosci
. 2024 Dec;
PMID: 39680139
Arketamine (R-ketamine), an enantiomer of ketamine, has historically been less studied than esketamine (S-ketamine) and the racemic mixture. Recent preclinical studies suggest that arketamine may offer prolonged antidepressant effects and...
2.
Ramirez-Diaz A, Diaz-Zuluaga A, Stroud 2nd R, Vreeker A, Bitta M, Ivankovic F, et al.
medRxiv
. 2024 Nov;
PMID: 39502669
Background: The Populations Underrepresented in Mental illness Association Studies (PUMAS) project is attempting to remediate the historical underrepresentation of African and Latin American populations in psychiatric genetics through large-scale genetic...
3.
Caliman-Fontes A, Vieira F, Leal G, Carneiro B, Quarantini-Alvim Y, Andrade T, et al.
Schizophr Res
. 2024 Aug;
271:355-370.
PMID: 39098303
Introduction: Catatonia, documented since the 19th century, remains a significant challenge in terms of recognition and treatment. Over the last two decades, ketamine has brought new perspectives to psychiatry, sparking...
4.
Adelino M, Nunes M, Nunes M, Quarantini L, Hallak J, Lacerda A
Schizophr Res
. 2024 May;
269:114-115.
PMID: 38761435
No abstract available.
5.
Carneiro B, Franco Guerreiro-Costa L, Lins-Silva D, Faria Guimaraes D, Souza L, Leal G, et al.
Cureus
. 2024 Apr;
16(3):e56910.
PMID: 38665721
Despite the hardships of major depressive disorder (MDD), biomarkers for the diagnosis and pharmacological management of this condition are lacking. MicroRNAs are epigenetic mechanisms that could provide promising MDD biomarkers....
6.
Alves-Pereira R, Fontes M, Cordeiro V, Bandeira I, Faria-Guimaraes D, Silva S, et al.
Clin Neuropharmacol
. 2024 Jan;
47(1):17-21.
PMID: 38194244
Objective: Converging evidence supports the role of the glutamate, an excitatory amino acid neurotransmitter, in the pathophysiology of obsessive-compulsive disorder (OCD). Ketamine and esketamine, both noncompetitive N -methyl- d -aspartate...
7.
Crowley J, Cappi C, Ochoa-Panaifo M, Frederick R, Kook M, Wiese A, et al.
Am J Med Genet B Neuropsychiatr Genet
. 2023 Nov;
195(4):e32962.
PMID: 37946624
Obsessive-compulsive disorder (OCD) is a debilitating psychiatric disorder. Worldwide, its prevalence is ~2% and its etiology is mostly unknown. Identifying biological factors contributing to OCD will elucidate underlying mechanisms and...
8.
Caliman-Fontes A, Leal G, Gadelha A, Quarantini L
Braz J Psychiatry
. 2023 Oct;
45(5):461-462.
PMID: 37792800
No abstract available.
9.
Echegaray M, Mello R, Magnavita G, Leal G, Correia-Melo F, Jesus-Nunes A, et al.
Trends Psychiatry Psychother
. 2023 Sep;
PMID: 37717263
Background: Ketamine and esketamine have both shown significant antidepressant effects in treatment-resistant depression (TRD), and conflicting evidence suggests that induced dissociation by these drugs can be a clinical predictor of...
10.
Bandeira I, Leal G, Correia-Melo F, Souza-Marques B, Silva S, Lins-Silva D, et al.
J Psychiatr Res
. 2023 Jun;
164:229-234.
PMID: 37385001
There are significantly fewer options for the treatment of bipolar depression than major depressive disorder, with an urgent need for alternative therapies. In this pilot study, we treated six subjects...